ロード中...
Danazol mediates collateral sensitivity via STAT3/Myc related pathway in multidrug-resistant cancer cells
Multidrug resistance presents an obstacle in cancer treatment. Among numerous combative strategies, collateral sensitivity (CS) drugs have opened a new avenue to defeat cancer by exploiting selective toxicity against multidrug-resistant (MDR) cancer. In the present study, a clinically used synthetic...
保存先:
| 出版年: | Sci Rep |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group UK
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6690972/ https://ncbi.nlm.nih.gov/pubmed/31406162 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-019-48169-2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|